The forecast of mortality for malignant neoplasms of the colon, rectum, and anus in the US from 2024 to 2028 suggests a stable trend, with annual deaths remaining constant at 53.07 thousand from 2025 to 2028, following a slight decline in 2024 to 53.08 thousand from 2023 levels. This indicates an insignificant year-on-year variation, highlighting steadiness with no considerable fluctuations in mortality rates.

Future trends to watch for:

Advancements in early detection and treatment methods could impact mortality rates positively.
Public health initiatives focusing on lifestyle changes to prevent these cancers might influence future trends.
Continuous tracking of healthcare policy changes and access to care will be crucial in understanding long-term impacts.